Explore how the CamAPS FX automated insulin delivery system and AiDAPT trial data are transforming Type 1 Diabetes management and maternal health during pregnancy.

The CamAPS FX isn't just a better tool; it's a better way to care for people. It represents a fundamental shift in how we manage the third trimester, where traditional methods often struggle to keep up with rising insulin resistance.
An analysis of the cost effectiveness and clinical outcomes of the CamAPS FX automated insulin delivery system in the UK, specifically focusing on HbA1c improvement in pregnant women with type 1 diabetes, based on the provided research articles: 10_1177_19322968241231950_pdf 2.pdf and Syleouni et al. (2026).




The CamAPS FX is a significant advancement in maternal health as it was the first commercially approved automated insulin delivery system specifically for use during pregnancy. Unlike traditional methods that require manual adjustments, this system is designed to handle the unique physiological shifts and rising insulin resistance that occur during the third trimester. It allows for more aggressive glucose targets, helping mothers manage the immense pressure of hitting difficult health targets while their bodies change weekly.
The AiDAPT trial provided critical data on the effectiveness of the CamAPS FX automated insulin delivery system for pregnant women navigating Type 1 Diabetes. The trial looked at how this technology manages the complex physiology of the third trimester, where traditional diabetes management often struggles to keep up with increasing insulin resistance. The results highlight a fundamental shift in care, moving away from the status quo of manual dosing toward a more automated, data-driven approach for better outcomes.
The CamAPS FX system was built from the ground up using pregnancy-specific data, which allows it to support much more aggressive glucose management targets than standard systems. Specifically, it can help pregnant women maintain a glucose range of 4.5 to 5.0 millimoles per liter. This precision is vital for maternal health, as it helps mitigate the risks associated with the high stakes of pregnancy while the body's insulin needs are constantly shifting.
During the third trimester, women with Type 1 Diabetes often face extreme insulin resistance and a body physiology that shifts by the week, making manual dose adjustments feel like a daily marathon. Automated insulin delivery systems like CamAPS FX reduce the need for constant manual intervention and second-guessing of meals. By using pregnancy-specific algorithms, these systems provide a more reliable way to hit nearly impossible targets, ensuring better safety for both the mother and the baby.
From Columbia University alumni built in San Francisco
"Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."
"I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."
"Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."
"Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."
"Reading used to feel like a chore. Now it’s just part of my lifestyle."
"Feels effortless compared to reading. I’ve finished 6 books this month already."
"BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."
"BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."
"BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"
"It is great for me to learn something from the book without reading it."
"The themed book list podcasts help me connect ideas across authors—like a guided audio journey."
"Makes me feel smarter every time before going to work"
From Columbia University alumni built in San Francisco
